MWA
BMY icon

Marshall Wace Asia’s Bristol-Myers Squibb BMY Stock Holding History

Marshall Wace Asia’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-30,276
Closed -$1.78M – 135
2020
Q2 		$1.78M Buy
+30,276
New +$1.81M 0.04% 75
2018
Q2 		– Sell
-79,897
Closed -$5.05M – 94
2018
Q1 		$5.05M Buy
79,897
+39,418
+97% +$2.54M 0.16% 69
2017
Q4 		$2.48M Buy
40,479
+803
+2% +$50.2K 0.09% 81
2017
Q3 		$2.54M Buy
+39,676
New +$2.32M 0.12% 48

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Marshall Wace Asia's BMY Position: Q3 2020 in Review

Marshall Wace Asia sold out of Bristol-Myers Squibb (BMY) in Q3 2020, closing a stake of 30,276 shares — an estimated $1.78M sold.

Marshall Wace Asia first reported a position in BMY in Q3 2017 and held it in 4 quarters. The position peaked at $5.05M in Q1 2018. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

  • Marshall Wace Asia reported no remaining Bristol-Myers Squibb position as of Q3 2020 after selling out during the quarter.
  • Marshall Wace Asia sold 30,276 Bristol-Myers Squibb shares in Q3 2020, an estimated $1.78M.
  • Marshall Wace Asia first reported a position in Bristol-Myers Squibb in Q3 2017 and held it in 4 quarters.
  • Marshall Wace Asia's Bristol-Myers Squibb position peaked at $5.05M in Q1 2018.
  • 2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on Marshall Wace Asia's 13F filing for Q3 2020, filed 16 Nov 2020.